⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for programmed cell death 1 receptor

Every month we try and update this database with for programmed cell death 1 receptor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple MyelomaNCT03111992
Multiple Myelom...
PDR001
CJM112
LCL161
18 Years - Novartis
Biomarkers in Urothelial Cancer Patients Treated With PembrolizumabNCT03263039
Transitional Ce...
Biomarkers
Pembrolizumab
18 Years - Erasmus Medical Center
Biomarkers in Urothelial Cancer Patients Treated With PembrolizumabNCT03263039
Transitional Ce...
Biomarkers
Pembrolizumab
18 Years - Erasmus Medical Center
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal CancerNCT06024356
Colorectal Neop...
Thymalfasin
18 Years - Beijing Friendship Hospital
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple MyelomaNCT03111992
Multiple Myelom...
PDR001
CJM112
LCL161
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: